KOMBINACINĖS TERAPIJOS CHEMORESISTENCINIŲ VĖŽIŲ GYDYMUI

• 收藏
• 分享

专利权人:

MEI Pharma; Inc.

发明人:

GOLD, Daniel,GARCIA-MANERO, Guillermo

申请号：

LT13851971

公开号：

LT2914254T

申请日:

2013.10.30

申请国别(地区):

LT

年份:

2020

代理人:

摘要：

Provided herein are methods of treating a disease or disorder associated with dysregulation of histone deacetylase, and more specifically sensitizing and treating chemoresistant cancer comprising administering a therapeutically effective amount of a combination comprising a benzimidazole compound and a DNA hypomethylating agent and kits containing said combination. The preferred DNA hypomethylating agent used in the method is 5-azacitidine azacitidine.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/